These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11346139)

  • 1. Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
    Chuang CH; Sheu BS; Yang HB; Wu JJ; Lin XZ
    Dig Liver Dis; 2001 Mar; 33(2):125-30. PubMed ID: 11346139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A
    Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ; Malekzadeh R; Vahedi H; Sotoudeh M; Kamalian N; Amini M; Massarrat S
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.
    Ell C; Schoerner C; Solbach W; Stolte M; Vieth M; Ridl W; Moser W;
    Eur J Gastroenterol Hepatol; 2001 Jun; 13(6):685-91. PubMed ID: 11434595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
    Hung WK; Wong WM; Wong GS; Yip AW; Szeto ML; Lai KC; Hu WH; Chan CK; Xia HH; Yuen MF; Fung FM; Tong TS; Ho VY; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2067-72. PubMed ID: 12452939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
    Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
    Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
    Neville PM; Barrowclough S; Crocombe W; Axon AT; Wrangstadh M; Moayyedi P
    Dig Liver Dis; 2001 Mar; 33(2):131-4. PubMed ID: 11346140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of ranitidine bismuth citrate plus amoxycillin and clarithromycin as first- or second-line therapy to cure Helicobacter pylori infection.
    Tursi A; Brandimarte G; Giorgetti G; Modeo ME; Gigliobianco A
    Hepatogastroenterology; 2002; 49(46):1006-9. PubMed ID: 12143188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-week triple therapy using omeprazole, amoxycillin and clarithromycin for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia: influence of dosage of omeprazole and clarithromycin.
    Bigard MA; Delchier JC; Riachi G; Thibault P; Barthelemy P
    Aliment Pharmacol Ther; 1998 Apr; 12(4):383-8. PubMed ID: 9690730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor efficacy of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori eradication.
    Uygun A; Kadayifci A; Yesilova Z; Ates Y; Safali M; Ilgan S; Bagci S; Dagalp K
    Indian J Gastroenterol; 2007; 26(4):174-7. PubMed ID: 17986746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
    Gisbert JP; Gisbert JL; Marcos S; Grávalos RG; Carpio D; Pajares JM
    Aliment Pharmacol Ther; 1999 Oct; 13(10):1311-6. PubMed ID: 10540045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
    Buzás GM
    Orv Hetil; 2004 Oct; 145(42):2141-5. PubMed ID: 15566071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
    Labenz J; Rühl GH; Bertrams J; Börsch G
    Aliment Pharmacol Ther; 1994 Jun; 8(3):323-7. PubMed ID: 7918928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
    Wong BC; Wong WM; Wang WH; Fung FM; Lai KC; Chu KM; Yuen ST; Leung SY; Hu WH; Yuen MF; Lau GK; Chan CK; Lam SK
    Aliment Pharmacol Ther; 2001 Mar; 15(3):403-9. PubMed ID: 11207516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Catalano F; Catanzaro R; Bentivegna C; Brogna A; Condorelli G; Cipolla R
    Aliment Pharmacol Ther; 1998 Jan; 12(1):59-62. PubMed ID: 9692702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Grimley CE; Penny A; O'sullivan M; Shebani M; Lismore JR; Cross R; Illing RC; Loft DE; Nwokolo CU
    Aliment Pharmacol Ther; 1999 Jul; 13(7):869-73. PubMed ID: 10383520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.